Skip to content

Nurse-led Consultations in Heart Failure Within the 'FIL-EAS' Evaluation and Support Care Pathway for Heart Failure Patients

Nurse-led Consultations in Heart Failure Within the 'FIL-EAS' Evaluation and Support Care Pathway for Heart Failure Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06853353
Acronym
ISPIC FILEAS
Enrollment
152
Registered
2025-02-28
Start date
2025-02-25
Completion date
2025-12-31
Last updated
2026-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Heart Failure

Keywords

Chronic heart failure, Nurse, Heart Failure Nurse Specialists, Advanced practice nursing, Treatment titration, Care pathway

Brief summary

The management of chronic heart failure, following current guidelines, requires the implementation and adjustment of therapies to limit mortality and morbidity associated with disease progression. However, this period of treatment titration remains challenging due to the need for multiple, closely spaced consultations. The difficulty in maintaining this consultation frequency, coupled with the current decline in medical demographics, largely explains the lack of treatment titration or even initiation and the existing therapeutic inertia. Concurrently, medical telemonitoring is emerging as an essential tool in heart failure management, offering significant benefits for both patients and healthcare professionals. In this context, new forms of nursing practices have emerged, such as advanced practice nursing, aimed at improving the care of patients with chronic diseases. However, only limited data are currently available regarding the functioning and impact of these consultations in France. The "Evaluation and Support Pathway for Heart Failure Patients (FIL-EAS ic)" has systematically integrated this new model of consultations provided by heart failure nurse specialists. Given their significant and growing role within the pathway, it appears necessary to thoroughly evaluate these consultations to propose improvements and maximize their effectiveness.

Interventions

OTHERHeart Failure Specialist Nurses consultations

Heart Failure Specialist Nurses consultations

Sponsors

Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Aged 18 years old or over * Patient seen in nurse-led consultations for heart failure between January 1, 2023 and December 31, 2023

Exclusion criteria

* Patient opposition to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Type of consultation1-year periodMedical telemonitoring, treatment titration, advanced practice nurse follow-up
Patient's medical history1-year periodPatient's clinical characteristics will be analyzed : number and type of medical histories
Treatments implemented1-year periodType and dose of treatment initiated for heart failure will be analyzed.
Number of consultations1-year periodThe number of consultations will be analyzed by type of activity (medical telemonitoring, treatment titration, advanced practice nurse follow-up).
Number of hospitalizations1-year periodThe number of hospitalizations and re-hospitalizations during the 12 months of follow-up will be analyzed.

Secondary

MeasureTime frameDescription
Type of referral1-year periodThe type of referral will be analyzed : in-hospital (cardiology or non-cardiology) or out-of-hospital (cardiologist, general practitioner, private nurse or Advanced Practice Registered Nurse)
Reason for discontinuation of titration consultation1-year periodThe reason for the discontinuation of titration consultations will be analyzed.
Left ventricular ejection fraction (LVEF)1-year periodEchocardiography data during therapy titration will be analyzed.
Modification of recommended treatment doses1-year periodModification of recommended treatment doses in heart failure will be analyzed in the overall cohort and according to the level of LVEF at initial management.
Rate of detection of iron deficiency1-year periodThe rate of detection of iron deficiency will be analyzed according to whether or not Ferinject supplementation is used.

Countries

France

Contacts

STUDY_DIRECTORMathilde LE CAIGNEC, Nurse

Centre Hospitalier Intercommunal Toulon La Seyne sur Mer

STUDY_DIRECTORJocelyne CANDEL, Advanced Practice Nurse

Centre Hospitalier Intercommunal Toulon La Seyne sur Mer

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 8, 2026